Taken together, our data indicate that LBP plays a vital role in the regulation of hepatic lipid metabolism and that pharmacological activation of SIRT1 by LBP may be a strategy for the prevention of NAFLD. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.